ODRIMEDIA NEWS’ Post

Understanding the Gleason Score: A Key to Prostate Cancer Management Prostate cancer remains one of the most common cancers affecting men worldwide. Early detection is crucial for effective treatment, and one of the most important tools used to understand the behavior of prostate cancer is the Gleason score. This score, derived from a prostate biopsy, provides crucial insights into how aggressive the cancer is and #Gleason #ProstateCancer >>> Read more

Fusobacterium nucleatum also implicated in vascular inflammation and atherosclerosis in apoE-/- mice via increased plasma NO, IL-1β, IL-13, IL-4, lymphotactin, and the regulated chemokine (upon on activation normal T cell expressed and secreted factor (RANTES). See Sasanka S Chukkapalli et al. PLoS One. 2015. https://lnkd.in/gnS4Esui

As CNN reports, researchers are looking to blood-based biomarkers as an innovative early detection tool for pancreatic cancer. Dr. Brian Wolpin, director of the Gastrointestinal Cancer Center at Dana-Farber Cancer Institute, explains that the lack of screening tests means too many patients are being diagnosed in the later, more lethal stages of this disease. “The more patients we can find early, the greater the chance we have to cure patients of pancreatic cancer and start to reverse the statistics.” These sentiments are exactly why we are proudly investing in MD Anderson Cancer Center's study that is harnessing AI to integrate imaging and blood-based biomarkers. Learn more: https://lnkd.in/gyp_36Cb #pancreaticcancer #cancerresearch #cancerscreening #earlydetection

Pancreatic Cancer is the third leading cause of cancer deaths in the US, with no test for early detection. Will that change? Will it come from liquid biopsies? Read to find out the latest. https://lnkd.in/g3CNQD3g #cancer #pancreaticcancer #cancerdetection #cancerprevention #cancersurvivor #cancertest #liquidbiopsy

During a presentation at the 2024 American Association for Cancer Research, Dr. Andrew Vickers, a biostatistician at Memorial Sloan Kettering Cancer Center(MSK), sought to raise awareness about the best way to use the PSA test for prostate cancer screening. Here, Dr. Vickers, an expert in health outcomes related to the detection and treatment of prostate cancer, provides a recap of common myths about PSA tests and prostate cancer screening: https://bit.ly/3Jeiskq #AACR24

May is #BladderCancerAwareness Month and although it's mainly diagnosed in people over the age of 55, it's never too early to start educating yourself for prevention! It still is the sixth most common cancer in the US.... and did you know that smoking causes approximately HALF of all bladder cancer cases? Learn more about bladder cancer here: https://loom.ly/J4LKQV0 #bladdercancer #oncologyfacts #oncology #cancertreatment

For prostate cancer to cause symptoms, it may be at an advanced stage when it becomes harder to cure. That’s why prostate cancer screening is so important. In this MD Anderson Cancer Center article, Lisly Chéry, MD, discusses the common symptoms of prostate cancer and steps that can be taken when it comes to screening and assessing risk. https://bit.ly/4c5wbao #prostatecancer #cancerscreening #earlycancerdetection

➡️ In a new study, microbes normally found in the mouth were discovered in about one-half of examined colorectal tumors well as in stool samples of many people with colorectal cancer. ➡️ Researchers reported that the microbes traveled from the mouth to the colon, going through the stomach and remaining intact when exposed to stomach acid. ➡️ The scientists hope this discovery can lead to new treatment options for people with colorectal cancer. Read the study here: https://loom.ly/jpwvy88

Castle Biosciences' TissueCypher® test can offer patients with Barrett's esophagus a clearer picture of their risk of developing esophageal cancer, which is the 8th most common form of cancer worldwide and the 6th leading cause of cancer death (due in part to late diagnoses). Learn more about how TissueCypher can help (via USA TODAY and Mediaplanet USA): https://lnkd.in/gMBycc73

March is Colorectal Cancer Awareness Month & Here are some important things to know: 70% of Colorectal Cancers are on the left side. Colorectal cancer is an umbrella term for colon cancer and rectal cancer. It’s common for left-side tumors to cause symptoms. It's common for people with left-side colorectal cancer to have changes in their bowel habits or blood in their stool. People with right-side tumors often show fewer symptoms. "We have learned that colon cancer can’t be viewed as one disease. We’re now looking at it as a complex disease with many subtypes and trying to develop targeted and personalized therapies that can be used depending on the specific type people have. Slowly and steadily, we are moving the bar for personalized therapy in colorectal cancer." #personalizedmedicine #cancerresearch #endcancer #colorectalcancerawareness